Itaru Yamamoto

2.7k total citations
110 papers, 2.2k citations indexed

About

Itaru Yamamoto is a scholar working on Molecular Biology, Hepatology and Nutrition and Dietetics. According to data from OpenAlex, Itaru Yamamoto has authored 110 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Hepatology and 19 papers in Nutrition and Dietetics. Recurrent topics in Itaru Yamamoto's work include Liver physiology and pathology (19 papers), Vitamin C and Antioxidants Research (16 papers) and Phytochemicals and Antioxidant Activities (11 papers). Itaru Yamamoto is often cited by papers focused on Liver physiology and pathology (19 papers), Vitamin C and Antioxidants Research (16 papers) and Phytochemicals and Antioxidant Activities (11 papers). Itaru Yamamoto collaborates with scholars based in Japan, United States and South Korea. Itaru Yamamoto's co-authors include Eiichi Gohda, Akihiro Tai, Hitoshi Ohmori, Norio Muto, Jun Takebayashi, Mari Tanaka, Yoshihito Fujinami, Hirotoshi Kataoka, Hirohito Tsubouchi and Heitaroh Iwata and has published in prestigious journals such as Gastroenterology, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Itaru Yamamoto

108 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itaru Yamamoto Japan 27 702 512 362 322 293 110 2.2k
Henryk Taper Belgium 30 998 1.4× 1.0k 2.0× 69 0.2× 125 0.4× 131 0.4× 68 2.3k
Kazunori Fukuda Japan 25 1.3k 1.9× 125 0.2× 174 0.5× 156 0.5× 218 0.7× 66 2.7k
Ping Zhao China 28 1.5k 2.1× 118 0.2× 238 0.7× 225 0.7× 341 1.2× 147 2.9k
Brigitte Marian Austria 36 2.3k 3.2× 237 0.5× 83 0.2× 177 0.5× 173 0.6× 111 3.8k
Francesca Capone Italy 25 607 0.9× 315 0.6× 132 0.4× 84 0.3× 60 0.2× 51 1.6k
Kyu Lim South Korea 31 1.5k 2.1× 500 1.0× 115 0.3× 42 0.1× 242 0.8× 83 3.1k
H Taper Belgium 21 662 0.9× 485 0.9× 137 0.4× 53 0.2× 118 0.4× 55 1.5k
Tinghong Ye China 38 1.9k 2.7× 223 0.4× 410 1.1× 70 0.2× 265 0.9× 126 4.1k
Douglas J. Kornbrust United States 27 1.5k 2.2× 170 0.3× 32 0.1× 217 0.7× 306 1.0× 39 2.8k
Sung‐Kwon Moon South Korea 30 1.5k 2.1× 141 0.3× 41 0.1× 312 1.0× 310 1.1× 98 3.1k

Countries citing papers authored by Itaru Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Itaru Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itaru Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itaru Yamamoto more than expected).

Fields of papers citing papers by Itaru Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itaru Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itaru Yamamoto. The network helps show where Itaru Yamamoto may publish in the future.

Co-authorship network of co-authors of Itaru Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Itaru Yamamoto. A scholar is included among the top collaborators of Itaru Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itaru Yamamoto. Itaru Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichiyama, Kenji, et al.. (2009). Promotion of IL-4- and IL-5-dependent differentiation of anti-μ-primed B cells by ascorbic acid 2-glucoside. Immunology Letters. 122(2). 219–226. 23 indexed citations
2.
Ichiyama, Kenji, Akihiro Tai, & Itaru Yamamoto. (2007). Augmentation of Antigen-Specific Antibody Production and IL-10 Generation with a Fraction from Rooibos (Aspalathus linearis) Tea. Bioscience Biotechnology and Biochemistry. 71(2). 598–602. 8 indexed citations
3.
Yagi, Yasuyuki, et al.. (2003). Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition. Biochemical Pharmacology. 66(9). 1797–1808. 14 indexed citations
4.
Tai, Akihiro, et al.. (2003). Vitamin C Activity in Guinea Pigs of 6-O-Acyl-2-O-α-D-glucopyranosyl-L- ascorbic Acids with a Branched-acyl Chain. Bioscience Biotechnology and Biochemistry. 67(8). 1675–1682. 14 indexed citations
5.
6.
Liu, Jie, Takahito Yagi, Hiroshi Sadamori, et al.. (2003). Annexin V assay-proven anti-apoptotic effect of ascorbic acid 2-glucoside after cold ischemia/reperfusion injury in rat liver transplantation.. PubMed. 57(5). 209–16. 16 indexed citations
7.
Gohda, Eiichi, et al.. (2003). Augmentation by 2‐Mercaptoethanol of In Vitro Anti‐TNP Antibody Production Induced by Butyrate Plus IL‐2 in Murine Splenic B Cells. Immunopharmacology and Immunotoxicology. 25(4). 539–550. 1 indexed citations
8.
Mori, Shuji, Ryoko Shinohata, Hideo Takahashi, et al.. (2003). Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin. Cell and Tissue Research. 312(3). 353–359. 14 indexed citations
9.
Yamamoto, Itaru, et al.. (1997). Interleukin-2-dependent augmentation of the anti-tnp antibody production by sodium butyrate in cultured murine splenic b cells. International Journal of Immunopharmacology. 19(6). 347–354. 8 indexed citations
10.
Nakamura, Shuji, et al.. (1995). Heptocyte Growth Factor-Pleiotropic Cytokine Produced by Human Leukemia cells. Leukemia & lymphoma. 19(3-4). 197–205. 30 indexed citations
11.
Tanaka, Mari, Norio Muto, Eiichi Gohda, & Itaru Yamamoto. (1994). Enhancement by Ascorbic Acid 2-Glucoside or Repeated Additions of Ascorbate of Mitogen-Induced IgM and IgG Productions by Human Peripheral Blood Lymphocytes. The Japanese Journal of Pharmacology. 66(4). 451–456. 37 indexed citations
12.
Yamamoto, Itaru, Mari Tanaka, & Norio Muto. (1993). Enhancement of In vitro antibody production of murine splenocytes by ascorbic acid 2-O-α-glucoside. International Journal of Immunopharmacology. 15(3). 319–325. 28 indexed citations
13.
Yamamoto, Itaru, et al.. (1992). Collagen Synthesis in Human Skin Fibroblasts is Stimulated by a Stable Form of Ascorbate, 2-O-α-D-Glucopyranosyl-L-Ascorbic Acid. Journal of Nutrition. 122(4). 871–877. 87 indexed citations
14.
Gohda, Eiichi, Hirohito Tsubouchi, Hiroyuki Nakayama, et al.. (1991). Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. Digestive Diseases and Sciences. 36(6). 785–790. 9 indexed citations
15.
Ohmori, Hitoshi, et al.. (1987). The Use of β-Cyclodextrin-Containing Culture Medium for In Vitro Evaluation of Immunomodulating Agents. The Japanese Journal of Pharmacology. 44(2). 225–227. 1 indexed citations
16.
Yamamoto, Itaru, et al.. (1986). Development of Enzyme Immunoassay for Platonin® (NK 19). Journal of Immunoassay. 7(1-2). 17–35. 2 indexed citations
17.
Yamamoto, Itaru, et al.. (1983). Enzyme Immunoassays for β-Adrenoreceptor Blocking Agent, Befunolol and Its Main Metabolite, M1. Journal of Immunoassay. 4(4). 351–371. 3 indexed citations
18.
Yamamoto, Itaru, Hitoshi Ohmori, & Minoru Sasano. (1981). CCA: : An immunopharmacological profile. Ensho. 1(2). 281–286. 2 indexed citations
19.
20.
Yamamoto, Itaru, et al.. (1970). In vitro activation of monoamine oxidase in rat tissue homogenates by 4 (or 5)-diazoimidazole-5(or 4)-carboxamide. Biochemical Pharmacology. 19(5). 1831–1833. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henryk Taper Breakdown of academic impact, for papers by Kazunori Fukuda Breakdown of academic impact, for papers by Ping Zhao Breakdown of academic impact, for papers by Brigitte Marian Breakdown of academic impact, for papers by Francesca Capone Breakdown of academic impact, for papers by Kyu Lim Breakdown of academic impact, for papers by H Taper Breakdown of academic impact, for papers by Tinghong Ye Breakdown of academic impact, for papers by Douglas J. Kornbrust Breakdown of academic impact, for papers by Sung‐Kwon Moon
Rankless by CCL
2026